Objectives:

Knowing the current prevalence of hepatitis C virus infection has taken great importance nowdays due to the new advances in the treatment of hepatitis C virus infection in which the new direct-acting antivirals have demonstrated a high rate of sustained viral response.

Materials and methods:

This is a descriptive study based on the detection of anti VHC in the blood banks of “Ministerio de Salud del Perú” according to the information obtained from “Programa Nacional de Hemoterapia y Bancos de Sangre” (PRONAHEBAS).

Results:

In our study, the prevalence of anti-hepatitis C antibodies in blood donors nationwide was 0.428% in 2016 and 0.301% in 2017.

Conclusion:

To know updated data about the prevalence of hepatitis C virus infection in our population. It is the first step to be able to treat the disease and drastically reduce the infection rate according to the WHO target for 2030.

        · resumo em Espanhol     · texto em Espanhol     · Espanhol ( pdf )